TipRanks
Biolidics Ltd. (SG:8YY)
SGX:8YY
Singapore Market
Want to see SG:8YY full AI Analyst Report?

Biolidics Ltd. (8YY) Ratios

3 Followers

Biolidics Ltd. Ratios

SG:8YY's free cash flow for Q2 2026 was S$0.19. For the 2026 fiscal year, SG:8YY's free cash flow was decreased by S$ and operating cash flow was S$0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.39 1.17 0.35 0.22 0.99
Quick Ratio
1.39 1.17 0.35 0.22 0.98
Cash Ratio
0.45 0.50 0.15 0.10 0.84
Solvency Ratio
-0.71 -1.04 -1.13 -0.84 -1.05
Operating Cash Flow Ratio
0.36 -0.32 -1.21 -1.02 -0.51
Short-Term Operating Cash Flow Coverage
1.51 -1.38 -2.26 -1.82 -2.92
Net Current Asset Value
S$ -2.24MS$ -2.27MS$ -2.27MS$ -2.24MS$ -1.86M
Leverage Ratios
Debt-to-Assets Ratio
0.50 0.48 0.37 2.97 0.49
Debt-to-Equity Ratio
1.51 1.58 1.01 -1.02 -1.78
Debt-to-Capital Ratio
0.60 0.61 0.50 59.50 2.27
Long-Term Debt-to-Capital Ratio
0.54 0.58 0.28 -0.45 338.60
Financial Leverage Ratio
3.05 3.32 2.70 -0.34 -3.61
Debt Service Coverage Ratio
-7.50 -10.65 -2.86 -0.98 -6.59
Interest Coverage Ratio
-31.68 -40.27 -43.64 -8.97 -18.07
Debt to Market Cap
0.04 0.03 0.06 0.22 0.41
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Net Debt to EBITDA
-0.87 -0.51 -0.48 -1.58 0.24
Profitability Margins
Gross Profit Margin
30.65%36.83%23.85%52.71%46.73%
EBIT Margin
-44.27%-74.42%-401.53%-506.50%-388.99%
EBITDA Margin
-38.63%-69.42%-386.22%-419.49%-341.46%
Operating Profit Margin
-39.50%-61.27%-217.09%-359.57%-121.94%
Pretax Profit Margin
-45.45%-75.95%-406.51%-546.57%-395.74%
Net Profit Margin
-44.73%-75.34%-438.01%-898.19%-376.62%
Continuous Operations Profit Margin
-44.78%-75.39%-407.14%-546.57%-376.62%
Net Income Per EBT
98.42%99.20%107.75%164.33%95.17%
EBT Per EBIT
115.08%123.96%187.25%152.01%324.55%
Return on Assets (ROA)
-54.54%-78.04%-73.56%-364.81%-153.98%
Return on Equity (ROE)
-181.49%-259.46%-198.27%125.09%555.33%
Return on Capital Employed (ROCE)
-60.03%-81.30%-61.60%80.45%-3793.75%
Return on Invested Capital (ROIC)
-54.25%-75.44%-44.30%-2263.64%-215.55%
Return on Tangible Assets
-159.60%-300.15%-469.13%-364.81%-153.98%
Earnings Yield
-5.50%-4.45%-12.07%-32.27%-138.66%
Efficiency Ratios
Receivables Turnover
6.72 7.16 2.23 3.34 4.12
Payables Turnover
26.86 9.33 3.14 6.89 14.26
Inventory Turnover
0.00 0.00 0.00 11.91 49.11
Fixed Asset Turnover
17.99 250.43 12.06 1.10 14.82
Asset Turnover
1.22 1.04 0.17 0.41 0.41
Working Capital Turnover Ratio
22.32 -9.99 -0.57 -0.35 1.38
Cash Conversion Cycle
40.75 11.83 47.71 87.08 70.41
Days of Sales Outstanding
54.34 50.94 163.88 109.37 88.57
Days of Inventory Outstanding
0.00 0.00 0.00 30.65 7.43
Days of Payables Outstanding
13.59 39.11 116.16 52.94 25.60
Operating Cycle
54.34 50.94 163.88 140.02 96.01
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 >-0.01 >-0.01 >-0.01 -0.01
Free Cash Flow Per Share
<0.01 >-0.01 >-0.01 >-0.01 -0.01
CapEx Per Share
<0.01 0.00 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
0.99 1.00 1.00 1.00 1.03
Dividend Paid and CapEx Coverage Ratio
196.50 0.00 -385.50 0.00 -32.95
Capital Expenditure Coverage Ratio
196.50 0.00 -385.50 0.00 -32.95
Operating Cash Flow Coverage Ratio
0.14 -0.15 -1.32 -0.97 -1.02
Operating Cash Flow to Sales Ratio
0.06 -0.07 -2.95 -7.10 -1.23
Free Cash Flow Yield
0.70%-0.40%-8.15%-25.50%-46.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-16.84 -22.61 -8.29 -3.10 -0.72
Price-to-Sales (P/S) Ratio
8.14 16.93 36.30 27.84 2.72
Price-to-Book (P/B) Ratio
30.25 58.30 16.43 -3.88 -4.01
Price-to-Free Cash Flow (P/FCF) Ratio
141.87 -247.30 -12.27 -3.92 -2.14
Price-to-Operating Cash Flow Ratio
141.15 -247.30 -12.30 -3.92 -2.21
Price-to-Earnings Growth (PEG) Ratio
0.12 0.66 0.50 0.04 -0.02
Price-to-Fair Value
30.25 58.30 16.43 -3.88 -4.01
Enterprise Value Multiple
-21.92 -24.89 -9.88 -8.22 -0.56
Enterprise Value
57.75M 90.89M 29.91M 9.55M 4.74M
EV to EBITDA
-21.92 -24.89 -9.88 -8.22 -0.56
EV to Sales
8.47 17.28 38.15 34.48 1.91
EV to Free Cash Flow
147.70 -252.46 -12.90 -4.86 -1.50
EV to Operating Cash Flow
146.95 -252.46 -12.93 -4.86 -1.55
Tangible Book Value Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
<0.01 <0.01 <0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
0.01 <0.01 >-0.01 0.00 0.05
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
>-0.01 >-0.01 >-0.01 >-0.01 -0.03
Tax Burden
0.98 0.99 1.08 1.64 0.95
Interest Burden
1.03 1.02 1.01 1.08 1.02
Research & Development to Revenue
0.00 0.00 <0.01 0.11 0.09
SG&A to Revenue
0.05 0.00 2.49 0.00 0.00
Stock-Based Compensation to Revenue
0.12 0.15 1.07 0.00 -0.03
Income Quality
-0.13 0.09 0.67 0.79 0.31
Currency in SGD